Skip to main content
CDC Website

Physicians

What Are the Risks of Untreated Hep C?

This webpage explores the risks of untreated hepatitis C, highlighting its potential to cause severe liver damage, cirrhosis, liver failure, and even liver cancer. Beyond liver-related issues, the virus can also contribute to complications such as fatigue, joint pain, kidney disease, and diabetes. Early diagnosis and treatment are essential to preventing these long-term health risks and improving overall well-being.

Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022

This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.

Doxy PEP Doxycycline Post-Exposure Prophylaxis (Doxy PEP) Protocol

This guideline outlines the Doxy-PEP Protocol for the prevention of certain sexually transmitted infections (STIs), specifically targeting syphilis, gonorrhea, and chlamydia, following potential exposure. It provides guidelines for healthcare providers on how to administer doxycycline as post-exposure prophylaxis (PEP), detailing protocols for prescription, timing, and patient education to reduce the risk of infection.

Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains

This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies. The findings emphasize the need for continued research to address antibiotic resistance and enhance global TB control efforts.

Study Finds Lack of Testing for Gonorrhea, Chlamydia During Pregnancy

This webpage highlights a recent study that reveals gaps in gonorrhea and chlamydia testing during pregnancy. It emphasizes the potential health risks these infections pose to both mother and child, urging the need for improved screening protocols. The study underscores the importance of regular prenatal testing to ensure better health outcomes for both.

Doxy PEP is Plan B for Some STDs

This  video explains Doxy PEP, a preventive option for common STDs like syphilis, gonorrhea, and chlamydia. It highlights the importance of taking doxycycline within 72 hours of potential exposure, ideally within 24 hours.

You Have a Client With Hep C, Now What?

This fact sheet provides critical guidance for healthcare providers on managing patients with hepatitis C virus (HCV). It outlines key steps for diagnosis, treatment, and referral, emphasizing the importance of early detection and timely intervention. The fact sheet aims to equip healthcare providers with essential tools and resources to improve patient outcomes and prevent the spread of HCV through effective care strategies.

Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022

This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.

Was this page helpful? Give Feedback